| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |